Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update

Abstract Autosomal Dominant Polycystic Kidney Disease (ADPKD) affects up to 70 000 people in the UK and the most common inherited cause of end-stage kidney disease (ESKD). It is generally a late-onset multisystem disorder characterised by bilateral kidney cysts, liver cysts and an increased risk of...

Full description

Bibliographic Details

Published in:	BMC Nephrology
Main Authors:	Matt Gittus, Helen Haley, Tess Harris, Sarah Borrows, Neal Padmanabhan, Danny Gale, Roslyn Simms, Terri Williams, Aaron Acquaye, Alisa Wong, Melanie Chan, Eduardo Lee, Albert CM Ong
Format:	Article
Language:	English
Published:	BMC 2025-02-01
Subjects:	Autosomal Dominant polycystic kidney disease ADPKD Tolvaptan
Online Access:	https://doi.org/10.1186/s12882-025-03960-4